The pro-inflammatory cytokine TNF-α was the most prominent early biomarker of DSS-induced colitis based on its extensive up regulation during the onset of colitis induction and the fact that treatment of TNF-α neutralizing antibody significantly reduced DSS induced DAI. The gene discussed is TNF; the disease is colitis.